Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Nirma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Ac...more...
Alivus Life Sciences Limited has informed the Exchange about Schedule of Analyst/ Institutional Investor meeting.more...
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Analyst / Institutional Inve...more...
Alivus Life Sciences Limited has informed the Exchange about Schedule of meetmore...
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meetingmore...
Alivus Life Sciences Limited has informed the Exchange about Transcript of Earnings Call.more...
Please find enclosed herewith transcript of Earnings Call held on 15th May 2026 which is also made available on the website of the Company.more...
Alivus Life Sciences Limited has informed the Exchange about Schedule of Investors/Analyst Meeting.more...
Alivus Life Sciences Limited has informed the Exchange about Link of Earnings Call Recordingmore...
We hereby confirm that we have uploaded audio recording of the Q4 & FY2025-26 Earnings Call held on May 15 2026 on the website of the Company.more...
The company reported standalone net profit of Rs 162.66 crore for the quarter ended March 31 2026 as compared to Rs 141.87 crore in the same...more...
Please find enclosed herewith Investors Presentation for Q4 & FY 2025-26more...
Alivus Life Sciences Limited has informed the Exchange about Investor Presentationmore...
Enclosed please find herewith Press Release of the Company for the fourth quarter and year ended March 31 2026.more...
Alivus Life Sciences Limited has informed the Exchange regarding a press release dated May 14 2026 titled Press Release of the Company for t...more...
Alivus Life Sciences Limited has informed the Exchange regarding Allotment of 3100 Shares.more...
Enclosed please find herewith intimation with respect to allotment of Equity Shares under the \Employee Stock Option Scheme 2021\.more...
BOARD MEETINGS Company Name : Majestic Research Date : 30-06-2026